The Challenges — And Opportunities — Facing The European Biotech Industry

By Jonathan Hay

When it comes to capital investment and growth, the European biotech sector falls behind its counterparts in China and America. In 2020, China and the U.S. accounted for 67.5% of all biotechnology patents filed. Figures from the World Intellectual Property Organization show that Chinese and American depositary authorities, which collect deposits of micro-organisms for biotech patent procedures, were collecting thousands more deposits than European authorities.